President Joe Biden has issued an executive order delaying a final rule that compels community health centers receiving section 330e grant funds and partaking in the 340B drug-pricing program to provide insulin and injectable epinephrine at discounted rates to underprivileged patients until March 22. The temporary delay will allow department officials to further review the regulations, the order states.
Biden delays rule on insulin, epinephrine discounts
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.